MARKSANS PHARMA. Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Quarterly Results    (TCPH)

Here are the latest quarterly results of MARKSANS PHARMA.. For more details, see the MARKSANS PHARMA. financial fact sheet and MARKSANS PHARMA. share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

MARKSANS PHARMA. Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,5642,8763,3533,3123,5653,5843,3023,490 
Other income Rs m7900237-326059 
Turnover Rs m2,6432,8773,3543,3133,6013,5523,3623,548 
Expenses Rs m2,2282,4042,6622,6112,7332,6732,3482,716 
Gross profit Rs m336473692700832911954773 
Depreciation Rs m50739672190861375 
Interest Rs m2816201619172810 
Profit before tax Rs m337383576614659776972748 
Tax Rs m7788148120152187177122 
Profit after tax Rs m260296427494507589795626 
Gross profit margin %13.116.420.621.123.325.428.922.2 
Effective tax rate %22.822.925.819.623.024.118.216.3 
Net profit margin %10.110.312.714.914.216.424.117.9 
Diluted EPS Rs 0.6 0.7 1.0 1.2 1.2 1.4 1.9 1.5  
Diluted EPS (TTM) Rs NA 2.1 3.0 3.6 4.2 4.9 5.8 6.2  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Pharmaceuticals Company Quarterly Results:   BIOFIL CHEMICALS  ASPIRA PATHLAB & DIAGNOSTICS   SYNCOM HEALTHCARE  DISHMAN PHARMA  ANUH PHARMA  

Compare MARKSANS PHARMA. With:   BIOFIL CHEMICALS  ASPIRA PATHLAB & DIAGNOSTICS   SYNCOM HEALTHCARE  DISHMAN PHARMA  ANUH PHARMA  



Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MARKSANS PHARMA. SHARE PRICE


Oct 14, 2021 (Close)

TRACK MARKSANS PHARMA.

  • Track your investment in MARKSANS PHARMA. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MARKSANS PHARMA.

MARKSANS PHARMA. 5-YR ANALYSIS

COMPARE MARKSANS PHARMA. WITH

MARKET STATS